Epigenetic signature in persons with Down Syndrome
Explore this paper's citation graph
Summary
An epigenetic signature of Down Syndrome in blood cells that sustains a link between developmental defects and disease phenotype, including segmental premature aging is identified.
- Published
- 2015-05-11
- Cited by
- 0
- References
- 195
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:83529716
References
- Methylation of mouse liver DNA studied by means of the restriction enzymes msp I and hpa II.
- Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome.
- Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
- The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
- The novel roles of four and a half LIM proteins 1 and 2 in the cardiovascular system.
- Epigenetic regulation of aging.
- The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
- Cytogenetic Profile of Down Syndrome Cases Seen by a General Genetics Outpatient Service in Brazil.
- Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome.
- Oxidative stress, poly(ADP)ribosylation and aging: in vitro studies on lymphocytes from normal and Down's syndrome subjects of different age and from patients with Alzheimer's dementia.
- The Metabolic and Molecular Bases of Inherited Disease
- Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
- JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner
- Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype.
- The fundamental role of epigenetic events in cancer
- Atypical aging in Down syndrome.
- Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
- Identification of a DNA methylation signature in blood cells from persons with Down Syndrome
- From genomics to epigenomics: a loftier view of life
- Down syndrome: is it really characterized by precocious immunosenescence?
Cited by
No citing papers recorded for this paper.
Related papers
No related papers recorded.